Inhibition by pulmonary surfactant Curosurf of secretory phospholipase A2 expression in guinea-pig alveolar macrophages

Biochemical Pharmacology

Volumn 54, Issue 9, 1997, Pages 1055-1058

  Hidi, Rabiâ ^b   Vial, Daniel ^a   Havet, Nathalie ^a   Berger, Arnaud ^a   Vargaftig, B Boris ^a   Touqui, Lhousseine ^a  

^a INSTITUT PASTEUR   (France)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

ARDS; Guinea pig; Macrophages; PLA2; Surfactant

Indexed keywords

LUNG SURFACTANT EXTRACT; PHOSPHOLIPASE A2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; GENE EXPRESSION; GUINEA PIG; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SUBSTITUTION THERAPY;

ANIMALS; BIOLOGICAL PRODUCTS; ENZYME INHIBITORS; GUINEA PIGS; MACROPHAGES, ALVEOLAR; MALE; PHOSPHOLIPASES A; PHOSPHOLIPIDS; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0030724428     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00328-6     Document Type: Article

References (15)

1. Kollef MH and Schuster DP, The acute respiratory distress syndrome. N Eng J Med 332: 27-32, 1995.
2. Rivkind AL, Siegel JH, Guadalupi P and Littleton M, Sequential patterns of eicosanoid, platelet and neutrophil interactions in the evolution of fulminant post-traumatic ARDS. Ann Surg 210: 355-373, 1989.
3. Dennis E, Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem 269: 13057-13061, 1994.
4. Vadas P, Browning J, Edelson J and Pruzanski W, Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease state. J Lip Med 8: 1-30, 1993.
5. Kim D, Thompson B, Cockrill C, Hales C and Bonventre J, Bronchoalveolar fluid phospholipase A2 activities are increased in human adult respiratory distress syndrome. Am J Physiol 269: L109-L118, 1995.
6. Arbihe L, Vial D, Rosinski-Chupin I, Havet N, Vargaftig BB and Touqui L, Endotoxin induces expression of type-II phospholipase A2 in macrophages during acute lung injury in guinea-pig: involvement of TNF-α in LPS-induced type-II phospholipase A2 synthesis. J Immunol, in press.
7. Kobayashi T, Kataoka H, Ueda T, Murakami S, Takeda Y and Kokubo M, Effect of surfactant supplement and end-expira-tory pressure in lung-lavaged rabbits. J Appl Physiol 57: 995-1001, 1984.
8. Collaborative European Multicenter Study Group, Surfactant replacement therapy for severe neonatal respiratory distress syndrome. An international randomized clinical trial. Pediatrics 82: 683-691, 1988.
9. Robertson B, Curstedt T, Johansson J, Jörnvall H and Kobayashi T, Structural and functional characterisation of porcine surfactant isolated by liquid-gel chromatography. Prog Respir Res 25: 237-246, 1990.
10. Hidi R, Vargaftig BB and Touqui L, Increased synthesis and secretion of a 14 kDa phospholipase A2 by guinea-pig alveolar macrophages. J Immunol 151: 5613-5623, 1993.
11. Radvanyi F, Jordan L, Russo-Marie F and Bon C, A sensitive and continuous fluorometric assay for phospholipase A2 using pyrene-labelled phospholipids in the presence of serum albumin. Anal Biochem 177: 103-107, 1989.
12. Vial D, Senorale-Pose M, Havet N, Molio L, Vargaftig BB and Touqui L, Expression of the type-II phospholipase A2 in alveolar macrophages: down-regulation by an inflammatory signal. J Biol Chem 270: 17327-17332, 1995.
13. Thomassen MJ, Meeker DP, Antal JM, Connors MJ and Wiedeman HP, Synthetic surfactant (Exosurf®) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am J Respir Cell Mol Biol 7: 257-260, 1992.
14. Kadiri C, Cherqui C, Masliah J, Rybkine T, Etienne J and Bereziat G, Mechanism of N-Formyl-methionyl-Leucyl-phenylalanine-and platelet-activating factor-induced arachidonic acid release in guinea-pig alveolar macrophages. Mol Pharmacol 38: 418-425, 1990.
15. Gräbner R and Meerbach W, Phagocytosis of surfactant by alveolar macrophages in vitro. Am J Physiol 261: L472-L477, 1991.